Abstract:SummaryHuman pluripotent stem cell (hPSC)-derived endothelial cells and their progenitors may provide the means for vascularization of tissue-engineered constructs and can serve as models to study vascular development and disease. Here, we report a method to efficiently produce endothelial cells from hPSCs via GSK3 inhibition and culture in defined media to direct hPSC differentiation to CD34+CD31+ endothelial progenitors. Exogenous vascular endothelial growth factor (VEGF) treatment was dispensable, and endot… Show more
“…We previously demonstrated that activation of canonical Wnt signaling in hPSCs in LaSR basal medium generates functional CD34+/CD31+ endothelial progenitors in numerous hPSC lines (Lian et al, 2014). Figures 1A and S1 show schematics of the endothelial differentiation and purification protocols.…”
Section: Resultsmentioning
confidence: 99%
“…Recently, we reported a rapid and robust endothelial progenitor differentiation protocol under serum-free conditions, which only employs a Gsk-3β inhibitor in LaSR basal medium (Advanced DMEM/F12, 2.5 mM GlutaMAX and 60 μg/mL ascorbic acid) (Lian et al, 2014). The presence of bovine serum albumin (BSA) in this medium increases the cost, adds xenogenic components, and heightens lot-to-lot variability.…”
Human pluripotent stem cell (hPSC)-derived endothelial cells and their progenitors are important for vascular research and therapeutic revascularization. Here, we report a completely defined endothelial progenitor differentiation platform that uses a minimalistic medium consisting of Dulbecco's Modified Eagle Medium and ascorbic acid, lacking of albumin and growth factors. Following hPSC treatment with a GSK-3β inhibitor and culture in this medium, this protocol generates more than 30% multipotent CD34+CD31+ endothelial progenitors that can be purified to>95% CD34+ cells via magnetic activated cell sorting (MACS). These CD34+ progenitors are capable of differentiating into endothelial cells in serum-free inductive media. These hPSC-derived endothelial cells express key endothelial markers including CD31, VE-cadherin, and von Willebrand factor (vWF), exhibit endothelial-specific phenotypes and functions including tube formation and acetylated low-density lipoprotein (Ac-LDL) uptake. This fully defined platform should facilitate production of proliferative, xeno-free endothelial progenitor cells for both research and clinical applications.
“…We previously demonstrated that activation of canonical Wnt signaling in hPSCs in LaSR basal medium generates functional CD34+/CD31+ endothelial progenitors in numerous hPSC lines (Lian et al, 2014). Figures 1A and S1 show schematics of the endothelial differentiation and purification protocols.…”
Section: Resultsmentioning
confidence: 99%
“…Recently, we reported a rapid and robust endothelial progenitor differentiation protocol under serum-free conditions, which only employs a Gsk-3β inhibitor in LaSR basal medium (Advanced DMEM/F12, 2.5 mM GlutaMAX and 60 μg/mL ascorbic acid) (Lian et al, 2014). The presence of bovine serum albumin (BSA) in this medium increases the cost, adds xenogenic components, and heightens lot-to-lot variability.…”
Human pluripotent stem cell (hPSC)-derived endothelial cells and their progenitors are important for vascular research and therapeutic revascularization. Here, we report a completely defined endothelial progenitor differentiation platform that uses a minimalistic medium consisting of Dulbecco's Modified Eagle Medium and ascorbic acid, lacking of albumin and growth factors. Following hPSC treatment with a GSK-3β inhibitor and culture in this medium, this protocol generates more than 30% multipotent CD34+CD31+ endothelial progenitors that can be purified to>95% CD34+ cells via magnetic activated cell sorting (MACS). These CD34+ progenitors are capable of differentiating into endothelial cells in serum-free inductive media. These hPSC-derived endothelial cells express key endothelial markers including CD31, VE-cadherin, and von Willebrand factor (vWF), exhibit endothelial-specific phenotypes and functions including tube formation and acetylated low-density lipoprotein (Ac-LDL) uptake. This fully defined platform should facilitate production of proliferative, xeno-free endothelial progenitor cells for both research and clinical applications.
“…This is because of the nature of the serial plating method, where some iPSCs were lost during media replacement due to lack of adherent properties. Efficiency of MSC generation is difficult to establish and reports on iPSC-MSC or embryonic cell conversion often do not include efficiency data [52][53][54][55][56]. However, the flow cytometry results show that the cells that remained attached throughout iPSC-MSC conversion are homogenous and phenotypically similar to CB-MSCs.…”
Multipotent mesenchymal stromal cells (MSCs) are more and more frequently used to treat orthopedic injuries in horses. However, these cells are limited in their expandability and differentiation capacity. Recently, the first equine-induced pluripotent stem cell (iPSC) lines were reported by us [ 1 ]. In vitro differentiation of iPSCs into MSC-like cells is an attractive alternative to using MSCs derived from other sources, as a much larger quantity of patient-specific cells with broad differentiation potential could be generated. However, the differentiation capacity of iPSCs to MSCs and the potential for use in tissue engineering have yet to be explored. In this study, equine iPSCs were induced to differentiate into an MSC-like population. Upon induction, the iPSCs changed morphology toward spindle-shaped cells similar to MSCs. The ensuing iPSC-MSCs exhibited downregulation of pluripotency-associated genes and an upregulation of MSC-associated genes. In addition, the cells expressed the same surface markers as MSCs derived from equine umbilical cord blood. We then assessed the multilineage differentiation potential of iPSC-MSCs. Although chondrogenesis was not achieved after induction with transforming growth factor-beta 3 (TGFβ3) and/or bone morphogenic protein 4 (BMP-4) in 3D pellet culture, mineralization characteristic of osteogenesis and lipid droplet accumulation characteristic of adipogenesis were observed after chemical induction. We demonstrate a protocol for the derivation of MSC-like progenitor populations from equine iPS cells.
“…To search for specific miRNAs that affect EC differentiation via glycogen synthase kinase (GSK)-3β inhibition [15], we used a systematic bioinformatics database, TargetScan 6.2 (www.targets can.org). Based on the total context score (4 À 0.1) and the aggregated P CT score (4 0.5), we selected miR-26a, thus conferring stronger regulation than miRNAs with only one binding site ( Fig.…”
Section: Gsk3-β Inhibition Is Sufficient To Induce the Differentiatiomentioning
confidence: 99%
“…The inhibition of GSK-3β in ECFCs leads to increase in ECFC adhesion, survival, proliferation, differentiation, and angiogenic function, which results in accelerating re-endothelialization after vascular injury [12,13]. In addition, GSK-3β inhibition and VEGF exposure in human pluripotent cells induces differentiation of EC [14,15]. However, little is known about the mechanism through which these cells commit to becoming ECs.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.